Recreating scalp inflammation ex vivo: A human hair follicle-preserving model for immunotoxicological & therapeutic assessment
Emeline Pagès1, Emilie Braun1, Mathias Péries1, Oceane Grimaud1, Rached Ismail2, Philippe Mondon3, Jose Ginestar3 and Nicolas Gaudenzio1,5
1Genoskin SAS – 2Research Unit UR4312 CBSA, University of Rouen, Evreux, France – 3Sederma, Le Perray en Yvelines, France – 4CFEB SISLEY, Paris, France – 5Toulouse Institute of Infectious and Inflammatory Diseases (INFINITy), INSERM UMR1291, CNRS UMR5051, University of Toulouse, Toulouse, France
Recreating scalp inflammation in a human-relevant context
The scalp is a complex tissue where immune responses, inflammation, and hair follicle biology are closely interconnected. Dysregulated inflammatory processes contribute to several dermatological conditions, including seborrheic dermatitis, psoriasis, and different forms of alopecia. However, reproducing these mechanisms in a physiologically relevant experimental model remains challenging.
Genoskin’s HairSkin® model provides a human ex vivo platform containing mature hair follicles and pilosebaceous units, enabling the study of scalp biology, inflammatory pathways, and treatment responses in a native tissue environment.
Recent data demonstrate that topical LPS exposure induces a controlled inflammatory response while preserving overall tissue architecture and hair follicle morphology. The model reproduced key inflammatory signatures, including increased production of IL-8, GM-CSF, and MIP-1β, and showed changes in hair follicle cellular responses following inflammatory stimulation.
These findings support HairSkin® as a relevant platform for investigating mechanisms of scalp inflammation and evaluating the efficacy and safety of innovative scalp treatments under physiologically relevant conditions.
Please fill in the form below to access the full poster.
After submitting this form, you will receive an email with the link to access our poster.
Want more research like this in your inbox? Subscribe to our newsletter →
Comments are closed.
